Bad Food Fines? FDA Updates 2026 Reinspection Fees
Published Date: 7/30/2025
Notice
Summary
Starting in fiscal year 2026, the FDA is updating fees for checking food facilities again, handling recall slip-ups, and re-inspecting importers. If you run or import food businesses, expect some changes in costs and timing for these inspections. These updates help keep our food safe and make sure everyone plays by the rules.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 1 costs, 2 mixed.
Updated Fees for Facility Reinspections
If you run a domestic or foreign food facility, the FDA is updating the fees it charges for facility reinspections starting in fiscal year 2026. Expect changes in the costs and timing of these reinspections that affect businesses that operate or export food facilities.
Importer Reinspection Fee Changes
If you import food, the FDA is updating the fees for importer reinspections starting in fiscal year 2026. Importers should expect changes to inspection-related costs and possible timing impacts for imported food shipments.
Fees for Failure To Comply With Recall Orders
If you fail to comply with an FDA recall order, the agency is updating the fees for failures to comply starting in fiscal year 2026. Businesses subject to recall orders should expect updated financial penalties or fees tied to noncompliance.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
Previous / Next Documents
Previous: 2025-14413, Prescription Drug User Fee Rates for Fiscal Year 2026
The FDA is setting new fees for drug companies in fiscal year 2026 to help speed up the review of prescription drugs and biological products. If you’re a drug maker, expect some changes in how much you pay to get your products approved or stay on the market. These fees kick in starting October 1, 2025, so plan your budgets accordingly!
Next: 2025-14415, Food Safety Modernization Act Third-Party Certification Program User Fee Rate for Fiscal Year 2026
Starting in fiscal year 2026, the FDA is updating the fees for groups that check food safety under the Food Safety Modernization Act. This affects accreditation and certification bodies who want to get or keep their official approval. The new fees help keep food safety checks strong and fair, with changes kicking in soon to keep everyone on track.